Medicine and Dentistry
Neoplasm
100%
Triple Negative Breast Cancer
88%
Breast Cancer
83%
Metastatic Carcinoma
55%
Malignant Neoplasm
53%
Biological Marker
46%
Cancer Cell
41%
Cancer Types
37%
Functional Genomics
34%
Hippo Signaling
27%
Cell Adhesion Proteins
27%
Cell Therapy
27%
DNA Mismatch Repair
27%
Talazoparib
27%
Immune Checkpoint Blockade
27%
T Cell
27%
Monotherapy
27%
Tumor Microenvironment
27%
Carcinoembryonic Antigen
27%
Neoadjuvant Chemotherapy
27%
Stress
27%
Immunity
27%
Cell Signaling Pathway
27%
DNA Synthesis
23%
Tamsulosin
20%
Cancer Treatment
20%
Programmed Death-Ligand 1
18%
Mutational Load
18%
Patient Population
13%
Squamous Cell
13%
PARP1
13%
Cisplatin
13%
DNA Repair
13%
Short Hairpin RNA
13%
PARP Inhibitor
13%
The Cancer Genome Atlas
13%
Cell Line
13%
Lung Metastasis
12%
Primary Tumor
10%
Tumor Cell
9%
Genomic Signature
9%
Microsatellite Instability
9%
DNA Mismatch Repair Protein MSH2
9%
Tumor Infiltrating Lymphocyte
9%
Mutagenesis
9%
Gene Expression
9%
Mismatch Repair Protein
9%
Mutagenic Agent
9%
Ovarian Cancer Cell Line
9%
Mesenchymal-Epithelial Transition
9%
Biochemistry, Genetics and Molecular Biology
T Cell
65%
Genomics
62%
Immune Checkpoints
55%
Cancer Cell
43%
Reprogramming
41%
Genome Sequencing
41%
Functional Genomics
34%
Metabolic Pathway
34%
Tamsulosin
31%
Transcriptome
31%
Dynamics
31%
Regulatory Element
27%
Poly ADP Ribose Polymerase
27%
ARID1A
27%
Hippo Signaling Pathway
27%
Ubiquitin
27%
Doxorubicin
27%
Proteome
27%
Cell Adhesion Proteins
27%
Stress
27%
Drug Resistance
27%
Carcinoembryonic Antigen
27%
Anticancer
27%
Small Intestine
27%
Stem Cell
20%
DNA Repair
17%
DNA Synthesis
15%
PARP1
13%
Small Hairpin RNA
13%
Germline Mutation
13%
Histone H3
13%
BRCA2
13%
Cyclophosphamide
13%
Messenger RNA
13%
Minoxidil
13%
Cisplatin
13%
Drug Sensitivity
13%
SNAI1
13%
Germ Cell
13%
Germline
13%
Lipid Metabolism
13%
BRCA1
13%
Genetics
13%
Oxidative Phosphorylation
13%
Mesenchymal-Epithelial Transition
9%
Gene Expression
9%
Lymphocyte
9%
DNA Mismatch Repair
7%
Locus Control Region
6%
Tumor Suppressor Protein
6%
Keyphrases
Tumor Microenvironment
34%
Monotherapy
34%
T Cells
34%
Immune Checkpoint Therapy
29%
Ubiquitination Pathway
27%
Antitumor
27%
Tumor Immunity
27%
Triple-negative Breast Cancer
27%
Nave
27%
Adoptive Cell Therapy
27%
Multi-organ Metastasis
27%
ARID1A
27%
CTLA-4 Blockade
27%
Carcinoembryonic Antigen-related Cell Adhesion Molecule 5
27%
Accession number
27%
Talazoparib
27%
Immune Checkpoint Blockade
27%
Costimulation
27%
High-resolution
27%
Metastasis
27%
Cell State
27%
Biomarkers of Response
27%
Tumor-associated Macrophages
27%
Genome Analysis
27%
Cancer Types
27%
Cluster Assembly
27%
Breast Cancer
27%
T Helper
27%
M1-like
20%
CD4 T Cells
18%
Primary Tumor
16%
Tumor
15%
Combination Therapy
13%
DbGaP
13%
Anti-CTLA-4
13%
Regret
13%
Macrophages
13%
ATRi
13%
Data Availability
13%
PARP Inhibitor (PARPi)
13%
Pathological Complete Response
13%
Breast Cancer Patients
12%
CD8+ T Cells
11%
Ubiquitin
11%
Cancer Development
11%
Pathways in Cancer
11%
Intratumoral Heterogeneity
11%
Tumor Samples
11%
Subclone
11%
Tumoral
9%